Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)

SHE:300972 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	47,834	31,885	9,234	549.11	434.7	449.89
Other Revenue	443.67	443.67	60.17	0.15	-	0.1
Revenue	48,278	32,329	9,294	549.26	434.7	449.98
Revenue Growth (YoY)	93.06%	247.86%	1592.03%	26.35%	-3.40%	-0.21%
Cost of Revenue	42,693	28,869	8,440	462.11	391.7	325.24
Gross Profit	5,585	3,460	854.2	87.15	43.01	124.74
Selling, General & Admin	2,964	2,405	875.54	51.39	25.21	22.04
Research & Development	16.18	4.04	3.31	1.95	1.99	0.43
Other Operating Expenses	19.57	63.42	20.97	3.29	3.09	2.85
Operating Expenses	3,004	2,474	900.52	57.41	30.32	25.33
Operating Income	2,581	986.02	-46.32	29.74	12.68	99.41
Interest Expense	-55.72	-50.85	-28.75	-4.2	-5.18	-7.55
Interest & Investment Income	18.26	14.11	1.68	3.18	3.01	0.33
Currency Exchange Gain (Loss)	-0	-0	-0	-	-0	-0
Other Non Operating Income (Expenses)	3.67	-5.88	-7.22	-0.2	-0.07	0.03
EBT Excluding Unusual Items	2,547	943.4	-80.6	28.52	10.44	92.21
Gain (Loss) on Sale of Investments	-	-	-	0.2	0.03	-
Gain (Loss) on Sale of Assets	4.82	-8.3	-3.26	-1.66	-0.49	-0.1
Asset Writedown	-15.64	-11.05	-4.04	-0.31	-0.1	-0.05
Other Unusual Items	81.8	108.38	3.19	14.83	19.18	4.07
Pretax Income	2,618	1,032	-84.72	41.58	29.06	96.13
Income Tax Expense	769	429.18	61.3	0.04	5.61	-
Earnings From Continuing Operations	1,849	603.26	-146.02	41.54	23.45	96.13
Minority Interest in Earnings	-784.93	-309.74	63.1	6.2	-	-
Net Income	1,064	293.52	-82.93	47.74	23.45	96.13
Net Income to Common	1,064	293.52	-82.93	47.74	23.45	96.13
Net Income Growth	1744.96%	-	-	103.57%	-75.61%	4.28%
Shares Outstanding (Basic)	182	171	154	153	141	114
Shares Outstanding (Diluted)	199	187	154	155	141	114
Shares Change (YoY)	14.29%	21.78%	-0.92%	10.29%	22.92%	-0.69%
EPS (Basic)	5.85	1.71	-0.54	0.31	0.17	0.84
EPS (Diluted)	5.34	1.57	-0.54	0.31	0.17	0.84
EPS Growth	1514.26%	-	-	84.58%	-80.16%	5.00%
Free Cash Flow	2,174	731.69	804.17	-245.96	57.25	100.14
Free Cash Flow Per Share	10.92	3.91	5.23	-1.58	0.41	0.88
Dividend Per Share	0.550	0.600	-	-	0.220	-
Dividend Growth	175.00%	-	-	-	-	-
Gross Margin	11.57%	10.70%	9.19%	15.87%	9.89%	27.72%
Operating Margin	5.35%	3.05%	-0.50%	5.42%	2.92%	22.09%
Profit Margin	2.21%	0.91%	-0.89%	8.69%	5.39%	21.36%
Free Cash Flow Margin	4.50%	2.26%	8.65%	-44.78%	13.17%	22.25%
EBITDA	2,697	1,090	42.08	89.94	73.92	159.01
EBITDA Margin	5.59%	3.37%	0.45%	16.38%	17.00%	35.34%
D&A For EBITDA	115.73	104.02	88.4	60.2	61.24	59.61
EBIT	2,581	986.02	-46.32	29.74	12.68	99.41
EBIT Margin	5.35%	3.05%	-0.50%	5.42%	2.92%	22.09%
Effective Tax Rate	29.37%	41.57%	-	0.10%	19.31%	-
Revenue as Reported	48,278	32,329	9,294	549.26	434.7	449.98
Advertising Expenses	-	513.2	50.2	0.42	0.07	0.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.